Navigation Links
LORENZ' Response to New EU PV Legislation - Regulation No. 1235/2010 and EVMPD
Date:11/2/2011

FRANKFURT AM MAIN, Germany, Nov. 2, 2011 /PRNewswire/ -- LORENZ customers and business partners have successfully completed the first workshop on the new Requirements of Article 57(2) of Regulation (EC) 726/2004 and its impact on the industry. This marked the start of the LORENZ Special Interest Group for EVMPD – XEVPRM.

One of the hot topics in the regulated market space of drug registration are the Requirements of Article 57(2) of Regulation (EC) 726/2004. Since the EU has mandated the European Medicines Agency (EMA) to build a database for all registered product information within the European Union, many organizations are discussing and planning how to cope with the challenge to supply relevant data within a very aggressive time schedule. The legislation is effective and mandatory as of 2nd July 2012. A quote from the EMA website reads: "The legislation is the biggest change to the regulation of human medicines in the European Union (EU) since 1995. It has significant implications for applicants and holders of European Union marketing authorizations."

With this in mind, a strategic group of LORENZ customers and business collaborators came together on 24th October 2011 at LORENZ Headquarters in Frankfurt, Germany. In this workshop the complexity of the undertaking became clear, and the challenging timelines were reviewed.

"The data model, ease of use and proven track record of supplying a data entry platform will be key for our customers and coworkers", says Wolfgang Witzel, President of LORENZ Life Sciences Group. "There are several facts that we have to accept. Firstly, the draft specification has only been available since 1st September 2011. Secondly, further guidance is outstanding and questions on the specification still needs to be answered. Thirdly, example messages are outstanding. Fourthly, vocabularies are outstanding. And finally, on the technology side, both the Gateway and EVWeb supplied by EMA are not ready. This is a h
'/>"/>

SOURCE LORENZ Life Sciences Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
6. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
7. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
8. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
9. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
10. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
11. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ... Closures - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... for Surgical Incision Closures in US$ Million by the following ...
(Date:6/2/2015)... 2, 2015 Intarcia Therapeutics, Inc. ... from its recently announced synthetic royalty / equity convert ... Investors have purchased Convertible Limited Recourse Notes from Intarcia ... 2.0% of any future global net sales of ITCA ... Investors also have the option, commencing upon U.S. regulatory ...
(Date:6/2/2015)... 2, 2015 Stoltenberg Consulting , ... today announced the celebration of its 20-year anniversary ... U.S., since its inception in 1995. ... in the healthcare technology industry continues, we strive ... dedication to facilitating clients, organizational goals, understanding that ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... JOLLA, Calif., Oct. 21 Transdel Pharmaceuticals, Inc. (OTC ... company focused on developing topically administered products using its ... John N. Bonfiglio, Ph.D. as Chief Executive Officer and ... on Transdel,s Board of Directors. With over ...
... the world,s leading research and advisory firms for pharmaceutical and ... drug market will remain relatively flat, increasing from $2.8 billion ... States, France, Germany, Italy, Spain, United Kingdom and Japan. ... Epilepsy forecast a decline in overall sales through ...
Cached Medicine Technology:Transdel Pharmaceuticals Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President 2Transdel Pharmaceuticals Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President 3The Epilepsy Drug Market Will Remain Relatively Flat Through 2019 as Generic Erosion, Especially Within the Second-Generation Antiepileptic Drug Class, is Offset by the Launch of New Therapies 2
(Date:6/2/2015)... Angeles, CA (PRWEB) June 02, 2015 Highly ... have unveiled a plan to drive prolific change in the ... the TDC Team Dental Clinic offers a full ... an expert management structure for dental tourism. , Partnered with ... care team is committed to advancing dentistry and has earned ...
(Date:6/2/2015)... The term “Augmented Reality” was coined ... on the real world. Since then many promising technologies ... a map of the vasculature on the surface of ... , AccuVein, the leader in vein visualization, exemplifies this ... and such widespread adoption of its AccuVein AV400 devices ...
(Date:6/2/2015)... Radaris ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers can help users ... According to Psychology Today, humans are a curious species by ... is a part of human development. People are using the ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 MedPro Healthcare ... services to healthcare facilities, today announced the worldwide release ... effective mobile tool to help candidates find best jobs ... survey released in 2014, 9 in 10 job seekers ... their job search. , The MedPro Top Jobs app ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ZOOM+, the ... ZOOM+ Performance Health Insurance, announced today the opening of ... White 57 - a three-in-one complete dental exam, cleaning ... Jr. for kids. Like all ZOOM+ services, ZOOM+Smile can ... “Why shouldn’t the dentist office be as inviting as ...
Breaking Medicine News(10 mins):Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2
... economic downturn has exacerbated a global food crisis that ... the number of people who are malnourished. The ... three-day workshop to explore the implications of the food ... the effects of the economic crisis and escalating food ...
... ANGELES, July 7 NEUTROGENA(R), the #1 dermatologist recommended ... Sweepstakes, where one lucky grand-prize winner will win an ... the Fresh Faces of Music VIP Event. At the ... of NEUTROGENA(R) will listen to great music, have an ...
... Cystic Fibrosis Foundation announced today that all 50 states plus ... newborns be screened for cystic fibrosis (CF) by the year ... a life-threatening, genetic disease, can have a dramatic impact on ... , Newborn screening for CF was adopted nationwide at a ...
... Foods Market (Nasdaq: WFMI ), the leading ... the Non-GMO Project - a non-profit collaboration of manufacturers, ... to use the Non-GMO,s Product Verification Program (PVP) in ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090707/DA42720 ) , ...
... PALO ALTO, Calif., July 7, 2009 Jazz Pharmaceuticals, Inc. (Nasdaq: ... a private placement of an aggregate of 1,895,734 units, comprised of ... purchase up to 947,867 additional shares of common stock for aggregate ... price for a share of common stock and a warrant to ...
... July 7 Wound Care Innovations, LLC, a subsidiary ... it will exhibit at the New Cardiovascular Horizons and ... conference in New Orleans July 9-11. , ... the country, bringing together cardiologists, surgeons, podiatrists, wound care ...
Cached Medicine News:Health News:NEUTROGENA(R) Announces Fresh Faces Sweepstakes 2Health News:All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 3Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 4Health News:Jazz Pharmaceuticals Completes $7 Million Private Placement 2Health News:Wound Management Technologies, Inc Announces Conference Plans and Presentations on Advanced Wound Care Product 2Health News:Wound Management Technologies, Inc Announces Conference Plans and Presentations on Advanced Wound Care Product 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: